Low-level miR-646 in colorectal cancer inhibits cell proliferation and migration by targeting NOB1 expression

被引:26
|
作者
Dai, Huajia [1 ]
Hou, Kezhu [1 ]
Cai, Zujin [1 ]
Zhou, Qi [1 ]
Zhu, Song [1 ]
机构
[1] Shidong Hosp, Dept Gen Surg 1, Shanghai 200438, Peoples R China
关键词
renal cell carcinoma; miRNA; proliferation; migration; NOB1; COLON-CANCER; LUNG-CANCER; INVASION; SUPPRESSES; MICRORNAS; CARCINOMA; METASTASIS; PATHWAY; IDENTIFICATION; KNOCKDOWN;
D O I
10.3892/ol.2017.7032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aberrant expression of microRNA (miRNA) is important in the progression of various human cancers, however further investigation is required in order to fully elucidate mechanisms of and validate actions of endogenous non-coding RNAs. The present study demonstrated that the expression of miR-646 was downregulated in colorectal cancer tissues and cell lines. Notably, it was observed that miR-646, a tumor suppressor, inhibited colorectal cancer cell progression through directly targeting Nin one binding protein (NOB1) expression, which possesses anti-tumor properties in colorectal cancer. Furthermore, knockdown of NOB1 expression was responsible for the tumor-suppressive effect of miR-646. The findings suggest that miR-646 may act as a therapeutic target for the treatment of colorectal cancer.
引用
收藏
页码:6708 / 6714
页数:7
相关论文
共 50 条
  • [21] MiR-141 inhibits colorectal cancer cell proliferation and invasion by targeting PRKAR1A
    He, Xinxin
    Wei, Yangnian
    Liu, Ling
    Wang, Wen
    Wang, Yong
    Li, Nianfeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (08): : 8142 - 8151
  • [22] MiR-769 Inhibits Colorectal Cancer Cell Proliferation and Invasion by Targeting HEY1
    Han, Chao
    Song, Yingming
    Lian, Changhong
    MEDICAL SCIENCE MONITOR, 2018, 24 : 9232 - 9239
  • [23] MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET
    Han, Chao
    Zhou, Yubing
    An, Qi
    Li, Feng
    Li, Duolu
    Zhang, Xiaojian
    Yu, Zujing
    Zheng, Lili
    Duan, Zhenfeng
    Kan, Quancheng
    TUMOR BIOLOGY, 2015, 36 (09) : 6715 - 6723
  • [24] MiR-646 regulates proliferation and migration of laryngeal carcinoma through the PI3K/AKT pathway via targeting GPX1
    Yuan, Xuanju
    Liu, Yufeng
    Chen, E.
    Wang, Junhua
    Deng, Shouping
    Chen, Ping
    Wang, Xianhe
    Deng, Shouheng
    ORAL DISEASES, 2021, 27 (07) : 1678 - 1686
  • [25] miR-944 inhibits cell migration and invasion by targeting MACC1 in colorectal cancer
    Wen, Liqiang
    Li, Yingru
    Jiang, Zhipeng
    Zhang, Yuchao
    Yang, Bin
    Han, Fanghai
    ONCOLOGY REPORTS, 2017, 37 (06) : 3415 - 3422
  • [26] The LncRNA CASC11 Promotes Colorectal Cancer Cell Proliferation and Migration by Adsorbing miR-646 and miR-381-3p to Upregulate Their Target RAB11FIP2
    Zhang, Wei
    Li, Xiaomin
    Zhang, Wenjuan
    Lu, Yanxia
    Lin, Weihao
    Yang, Lawei
    Zhang, Zheying
    Li, Xuenong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] miR-144 suppresses cell proliferation and migration in colorectal cancer by targeting NRAS
    Ji, Xuemei
    Liu, Yanqing
    Kao, Xiaoming
    Chen, Xiaorui
    Zhao, Yi
    Zhang, Shuyan
    Chen, Liya
    Yu, Mengchao
    Wei, Juan
    Yang, Zhao
    Wang, Fangyu
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (8-9) : 3871 - 3881
  • [28] MiR-761 inhibits colorectal cancer cell proliferation and invasion through targeting HDAC1
    Xiong, Wei
    Yang, Shu
    Zhang, Wanfu
    Chen, Yesheng
    Wang, Feng
    PHARMAZIE, 2019, 74 (02): : 111 - 114
  • [29] miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1
    Wei, Wen-Ting
    Nian, Xin-Xin
    Wang, Shu-Yang
    Jiao, Hong-Li
    Wang, Yong-Xia
    Xiao, Zhi-Yuan
    Yang, Run-Wei
    Ding, Yan-Qing
    Ye, Ya-Ping
    Liao, Wen-Ting
    CANCER CELL INTERNATIONAL, 2017, 17
  • [30] miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1
    Wen-Ting Wei
    Xin-Xin Nian
    Shu-Yang Wang
    Hong-Li Jiao
    Yong-Xia Wang
    Zhi-Yuan Xiao
    Run-Wei Yang
    Yan-Qing Ding
    Ya-Ping Ye
    Wen-Ting Liao
    Cancer Cell International, 17